Lobular carcinoma in situ (LCIS) treatment in 772 Oncology clinics worldwide
772 clinics specializing in Oncology providing treatment of Lobular carcinoma in situ (LCIS) Lobular carcinoma in situ (LCIS) is a non-invasive breast cancer confined to the milk-producing lobules. It is not considered a true cancer but increases the risk of developing invasive breast cancer. Regular monitoring and preventive measures are often recommended. disease worldwide.
Sorted by:
Relevance
Rating
Relevance
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
Prices for popular procedures:
Milan, Italy
Specializations: Cardiac surgery, Vascular surgery, Thoracic surgery, Oncology
Languages: Arabic, English, Russian
The IEO (European Institute of Oncology) is one of the world's most prestigious hospitals and the fastest growing comprehensive cancer centre in Europe. IEO integrates
read more
Prices for popular procedures:
Clinics grouping by rating
Clinic with the highest rating of 5 — Berkana clinic in Moscow, Russia and 6 more, clinic with the most reviews number of 35757 — Aster CMI hospital in Bengaluru, India.
With rating 4.0 and over — 280 clinics .
Countries with the highest number of clinics treating the diseases:
Lobular carcinoma in situ (LCIS):
worldwide
774 clinics
India
42 clinics
Brazil
40 clinics
Mexico
34 clinics
Germany
33 clinics
United Kingdom
33 clinics
Related procedures:
Procedures are likely to be used for Lobular carcinoma in situ (LCIS) treatment:
Breast reconstruction after mastectomy,
Double preventive mastectomy,
Lumpectomy,
Needle biopsy,
and
Nipple and areola reconstruction
.